SOLENO THERAPEUTICS INC Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Product revenue, net
Operating expenses
Cost of goods sold
Research and development
Selling, general and administrative
General and administrative
Change in fair value of contingent consideration
Total operating expenses
Operating income (loss)
Other income (expense), net
Change in fair value of warrant liability
Interest income, net
Interest expense
Total other income (expense), net
Net Income Loss
Loss per common share, basic and diluted
Weighted-average common shares outstanding used to calculate basic and diluted net loss per common share
Other comprehensive income (loss)
Net unrealized gain on marketable securities
Foreign currency translation adjustment
Total comprehensive income (loss)
Less: Undistributed earnings attributable to participating securities, basic
Less: Undistributed earnings attributable to participating securities, diluted
Net income (loss) attributable to common stockholders - basic
Net income (loss) attributable to common stockholders - diluted
Net income (loss) per share - basic
Net income (loss) per share - diluted
Weighted-average common shares outstanding - basic
Weighted-average common shares outstanding - diluted

Comments